tradingkey.logo
tradingkey.logo

Tenaya Therapeutics Receives Positive Safety Reviews From Independent Dsmbs To Advance Both TN-201 And TN-401 Gene Therapy Clinical Trials As Designed

ReutersJul 30, 2025 1:26 PM

- Tenaya Therapeutics Inc TNYA.O:

  • TENAYA RECEIVES POSITIVE SAFETY REVIEWS FROM INDEPENDENT DSMBS TO ADVANCE BOTH TN-201 AND TN-401 GENE THERAPY CLINICAL TRIALS AS DESIGNED

  • TENAYA THERAPEUTICS INC: PLANS TO REPORT LONGER-TERM FOLLOW-UP DATA FROM COHORT 1 AND INITIAL DATA FROM COHORT 2 IN Q4 OF THIS YEAR

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI